TRIO-TECH INTERNATIONAL (TRT) Fundamental Analysis & Valuation

NYSEARCA:TRT • US8967122057

4.5 USD
-0.21 (-4.46%)
Last: Mar 3, 2026, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This TRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall TRT gets a fundamental rating of 4 out of 10. We evaluated TRT against 115 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for TRT as it has an excellent financial health rating, but there are worries on the profitability. TRT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. TRT Profitability Analysis

1.1 Basic Checks

  • In the past year TRT was profitable.
  • TRT had a positive operating cash flow in the past year.
  • In multiple years TRT reported negative net income over the last 5 years.
  • TRT had a positive operating cash flow in each of the past 5 years.
TRT Yearly Net Income VS EBIT VS OCF VS FCFTRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

  • TRT has a Return On Assets (0.57%) which is in line with its industry peers.
  • TRT has a Return On Equity of 0.80%. This is comparable to the rest of the industry: TRT outperforms 51.30% of its industry peers.
  • With a Return On Invested Capital value of 0.17%, TRT perfoms like the industry average, outperforming 48.70% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TRT is significantly below the industry average of 10.52%.
Industry RankSector Rank
ROA 0.57%
ROE 0.8%
ROIC 0.17%
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
TRT Yearly ROA, ROE, ROICTRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • The Profit Margin of TRT (0.64%) is comparable to the rest of the industry.
  • TRT has a Operating Margin (0.18%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of TRT has declined.
  • TRT has a Gross Margin of 22.30%. This is in the lower half of the industry: TRT underperforms 78.26% of its industry peers.
  • In the last couple of years the Gross Margin of TRT has grown nicely.
Industry RankSector Rank
OM 0.18%
PM (TTM) 0.64%
GM 22.3%
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
TRT Yearly Profit, Operating, Gross MarginsTRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. TRT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRT is destroying value.
  • TRT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TRT has more shares outstanding
  • TRT has a better debt/assets ratio than last year.
TRT Yearly Shares OutstandingTRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRT Yearly Total Debt VS Total AssetsTRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 3.67 indicates that TRT is not in any danger for bankruptcy at the moment.
  • TRT has a Altman-Z score of 3.67. This is comparable to the rest of the industry: TRT outperforms 51.30% of its industry peers.
  • The Debt to FCF ratio of TRT is 0.29, which is an excellent value as it means it would take TRT, only 0.29 years of fcf income to pay off all of its debts.
  • TRT's Debt to FCF ratio of 0.29 is amongst the best of the industry. TRT outperforms 81.74% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that TRT is not too dependend on debt financing.
  • The Debt to Equity ratio of TRT (0.01) is better than 66.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Altman-Z 3.67
ROIC/WACC0.02
WACC11.08%
TRT Yearly LT Debt VS Equity VS FCFTRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • TRT has a Current Ratio of 3.15. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
  • TRT's Current ratio of 3.15 is in line compared to the rest of the industry. TRT outperforms 53.91% of its industry peers.
  • TRT has a Quick Ratio of 2.95. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
  • TRT has a better Quick ratio (2.95) than 61.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.15
Quick Ratio 2.95
TRT Yearly Current Assets VS Current LiabilitesTRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TRT Growth Analysis

3.1 Past

  • The earnings per share for TRT have decreased strongly by -66.22% in the last year.
  • Looking at the last year, TRT shows a small growth in Revenue. The Revenue has grown by 0.10% in the last year.
  • Measured over the past years, TRT shows a small growth in Revenue. The Revenue has been growing by 1.14% on average per year.
EPS 1Y (TTM)-66.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%58.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRT Yearly Revenue VS EstimatesTRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

3

4. TRT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 225.00, the valuation of TRT can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as TRT.
  • When comparing the Price/Earnings ratio of TRT to the average of the S&P500 Index (26.83), we can say TRT is valued expensively.
Industry RankSector Rank
PE 225
Fwd PE N/A
TRT Price Earnings VS Forward Price EarningsTRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TRT is valued cheaply inside the industry as 98.26% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TRT is valued cheaply inside the industry as 93.04% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.66
EV/EBITDA 6.57
TRT Per share dataTRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRT Dividend Analysis

5.1 Amount

  • TRT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRT Fundamentals: All Metrics, Ratios and Statistics

TRIO-TECH INTERNATIONAL

NYSEARCA:TRT (3/3/2026, 8:04:00 PM)

4.5

-0.21 (-4.46%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-13
Earnings (Next)05-11
Inst Owners23.91%
Inst Owner Change-1.65%
Ins Owners25.8%
Ins Owner Change5.46%
Market Cap39.15M
Revenue(TTM)42.19M
Net Income(TTM)272.00K
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 225
Fwd PE N/A
P/S 0.93
P/FCF 17.66
P/OCF 12.39
P/B 1.15
P/tB 1.15
EV/EBITDA 6.57
EPS(TTM)0.02
EY0.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.25
FCFY5.66%
OCF(TTM)0.36
OCFY8.07%
SpS4.85
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 0.8%
ROCE 0.22%
ROIC 0.17%
ROICexc 0.34%
ROICexgc 0.34%
OM 0.18%
PM (TTM) 0.64%
GM 22.3%
FCFM 5.26%
ROA(3y)2.01%
ROA(5y)2%
ROE(3y)2.82%
ROE(5y)2.96%
ROIC(3y)2.81%
ROIC(5y)N/A
ROICexc(3y)5.18%
ROICexc(5y)N/A
ROICexgc(3y)5.18%
ROICexgc(5y)N/A
ROCE(3y)3.55%
ROCE(5y)N/A
ROICexgc growth 3Y-59.08%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.08%
ROICexc growth 5YN/A
OM growth 3Y-57.25%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.98%
GM growth 5Y3.52%
F-Score4
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Debt/EBITDA 0.14
Cap/Depr 36.85%
Cap/Sales 2.24%
Interest Coverage 1.86
Cash Conversion 119.74%
Profit Quality 815.07%
Current Ratio 3.15
Quick Ratio 2.95
Altman-Z 3.67
F-Score4
WACC11.08%
ROIC/WACC0.02
Cap/Depr(3y)45.5%
Cap/Depr(5y)44.1%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%143%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.1%
Revenue growth 3Y-6.11%
Revenue growth 5Y1.14%
Sales Q2Q%58.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.33%
EBIT growth 3Y-59.86%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.29%
OCF growth 3Y-44.07%
OCF growth 5Y-34.21%

TRIO-TECH INTERNATIONAL / TRT FAQ

Can you provide the ChartMill fundamental rating for TRIO-TECH INTERNATIONAL?

ChartMill assigns a fundamental rating of 4 / 10 to TRT.


Can you provide the valuation status for TRIO-TECH INTERNATIONAL?

ChartMill assigns a valuation rating of 3 / 10 to TRIO-TECH INTERNATIONAL (TRT). This can be considered as Overvalued.


Can you provide the profitability details for TRIO-TECH INTERNATIONAL?

TRIO-TECH INTERNATIONAL (TRT) has a profitability rating of 3 / 10.


What is the financial health of TRIO-TECH INTERNATIONAL (TRT) stock?

The financial health rating of TRIO-TECH INTERNATIONAL (TRT) is 7 / 10.